Title
Elevated baseline expression of seven virulence factor RNA transcripts in visceralizing species of Leishmania: a preliminary quantitative PCR study
Date Issued
01 January 2022
Access level
open access
Resource Type
journal article
Author(s)
Mukkala A.N.
Kariyawasam R.
Lau R.
Boggild A.K.
Publisher(s)
SAGE Publications Ltd
Abstract
Introduction: Leishmaniasis is a neglected tropical disease that manifests as three major disease phenotypes: cutaneous, mucocutaneous, and visceral. In this preliminary study, we quantified virulence factor (VF) RNA transcript expression in Leishmania species, stratified by geographic origin and propensity for specific disease phenotypes. Methods: Cultured promastigotes of 19 Leishmania clinical and ATCC isolates were extracted for total cellular RNA, cDNA was reverse transcribed, and qPCR assays were performed to quantify VF RNA transcript expression for hsp23, hsp70, hsp83, hsp100, mpi, cpb, and gp63. Results: Comparison of visceralizing species (Leishmania donovani, Leishmania chagasi, and Leishmania infantum) versus non-visceralizing species [Leishmania (Viannia) spp., Leishmania tropica, Leishmania major, Leishmania mexicana, and Leishmania amazonensis] revealed a significantly greater pooled transcript expression for visceralizing species (p = 0.0032). Similarly, Old World species demonstrated significantly higher VF RNA transcript expression than New World species (p = 0.0015). On a per-gene basis, species with a propensity to visceralize ubiquitously expressed higher levels of gp63 (p = 0.005), cpb (p = 0.0032), mpi (p = 0.0032), hsp23 (p = 0.0039), hsp70 (p = 0.0032), hsp83 (p = 0.0032), and hsp100 (p = 0.0032). Conclusion: Here, we provide quantitative, preliminary evidence of elevated VF RNA transcript expression driven largely by the visceralizing causative species of Leishmania. This work highlights the extensive heterogeneity in pathogenicity mechanisms between Leishmania species, which may partly underpin the fatal progression of visceral leishmaniasis.
Volume
9
Language
English
OCDE Knowledge area
Genética, Herencia
Parasitología
Subjects
Scopus EID
2-s2.0-85131330717
Source
Therapeutic Advances in Infectious Disease
ISSN of the container
20499361
Sponsor(s)
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the University of Toronto Department of Medicine, the University of Toronto Institute of Medical Science, and Public Health Ontario. A.K.B. is supported as a Clinician Scientist by the Departments of Medicine of both the University of Toronto and the University Health Network.
Sources of information:
Directorio de Producción Científica
Scopus